Kehm, R. D., Vilfranc, C. L., McDonald, J. A., & Wu, H.-C. (2025). County-Level Food Insecurity and Hepatocellular Carcinoma Risk: A Cross-Sectional Analysis. International Journal of Environmental Research and Public Health, 22(1), 120. https://doi.org/10.3390/ijerph22010120

Varanasi, S. K., Chen, D., Liu, Y., Johnson, M. A., Miller, C. M., Ganguly, S., Lande, K., LaPorta, M. A., Hoffmann, F. A., Mann, T. H., Teneche, M. G., Casillas, E., Mangalhara, K. C., Mathew, V., Sun, M., Jensen, I. J., Farsakoglu, Y., Chen, T., Parisi, B., … Kaech, S. M. (2025). Bile acid synthesis impedes tumor-specific T cell responses during liver cancer. Science, 387(6730), 192–201. https://doi.org/10.1126/science.adl4100

Fernández-Tussy, P., Cardelo, M. P., Zhang, H., Sun, J., Price, N. L., Boutagy, N. E., Goedeke, L., Cadena-Sandoval, M., Xirouchaki, C. E., Brown, W., Yang, X., Pastor-Rojo, O., Haeusler, R. A., Bennett, A. M., Tiganis, T., Suárez, Y., & Fernández-Hernando, C. (2024). miR-33 deletion in hepatocytes attenuates MASLD-MASH-HCC progression. JCI Insight, 9(19). https://doi.org/10.1172/jci.insight.168476

Elaimy, A. L., El-Derany, M. O., James, J., Wang, Z., Pearson, A. N., Holcomb, E. A., Huber, A. K., Gijón, M., Bell, H. N., Sanghvi, V. R., Frankel, T. L., Su, G. L., Tapper, E. B., Tai, A. W., Ramnath, N., Centonze, C. P., Dobrosotskaya, I., Moeller, J. A., Bryant, A. K., … Green, M. D. (2024). SLC4A11 mediates ammonia import and promotes cancer stemness in hepatocellular carcinoma. JCI Insight, 9(21). https://doi.org/10.1172/jci.insight.184826

Ibrahim, A., Guha, S., Lu, L., Geng, P., Wu, Q., Chou, Y., Yang, H., Wang, D., Schwartz, L. H., Xie, C., & Zhao, B. (2024). The reproducibility and predictivity of radiomic features extracted from dynamic contrast-enhanced computed tomography of hepatocellular carcinoma. PLOS ONE, 19(9), e0310486. https://doi.org/10.1371/journal.pone.0310486

Li, J., Su, P., Li, T., Hao, Y., Wang, T., Fu, L., & Liu, X. (2024). The Role and Clinical Relevance of Glycolysis‐Associated Genes on Immune Infiltration in Hepatocellular Carcinoma. Journal of Cellular Biochemistry, 125(8). Portico. https://doi.org/10.1002/jcb.30620

Kim, Y. Y., Lluri, G., Haeffele, C., Daugherty, T., Krasuski, R. A., Serfas, J. D., de Freitas, R. A., Porlier, A., Lubert, A. M., Wu, F. M., Valente, A. M., Krieger, E. V., Buber, J., Rodriguez, F. H., Gaignard, S., Saraf, A., Hindes, M., Earing, M. G., Lewis, M. J., … Hoteit, M. A. (2023). Hepatocellular carcinoma in survivors after Fontan operation: a case–control study. European Heart Journal, 45(16), 1477–1480. https://doi.org/10.1093/eurheartj/ehad788

Sharma, R., Simon, T. G., Hagström, H., Lochhead, P., Roelstraete, B., Söderling, J., Verna, E. C., Emond, J., & Ludvigsson, J. F. (2024). Statins Are Associated With a Decreased Risk of Severe Liver Disease in Individuals With Noncirrhotic Chronic Liver Disease. Clinical Gastroenterology and Hepatology, 22(4), 749-759.e19. https://doi.org/10.1016/j.cgh.2023.04.017

Ma, M., Ganapathi, M., Zheng, Y., Tan, K.-L., Kanca, O., Bove, K. E., Quintanilla, N., Sag, S. O., Temel, S. G., LeDuc, C. A., McPartland, A. J., Pereira, E. M., Shen, Y., Hagen, J., Thomas, C. P., Nguyen Galván, N. T., Pan, X., Lu, S., Rosenfeld, J. A., … Bellen, H. J. (2024). Homozygous missense variants in YKT6 result in loss of function and are associated with developmental delay, with or without severe infantile liver disease and risk for hepatocellular carcinoma. Genetics in Medicine, 26(7), 101125. https://doi.org/10.1016/j.gim.2024.101125

Abou-Alfa, G. K., Geyer, S. M., Nixon, A. B., Innocenti, F., Shi, Q., Kumthekar, P., Jacobson, S., El Dika, I., Yaqubie, A., Lopez, J., Huang, B., Tang, Y.-W., Wen, Y., Schwartz, L. H., El-Khoueiry, A. B., Knox, J. J., Rajdev, L., Bertagnolli, M. M., Meyerhardt, J. A., … Venook, A. P. (2024). CALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C Infection in Patients with Advanced Hepatocellular Carcinoma. Cancer Research Communications, 4(3), 682–690. https://doi.org/10.1158/2767-9764.crc-22-0516

Hassan, M. M., Li, D., Han, Y., Byun, J., Hatia, R. I., Long, E., Choi, J., Kelley, R. K., Cleary, S. P., Lok, A. S., Bracci, P., Permuth, J. B., Bucur, R., Yuan, J.-M., Singal, A. G., Jalal, P. K., Ghobrial, R. M., Santella, R. M., Kono, Y., … Amos, C. I. (2024). Genome-wide association study identifies high-impact susceptibility loci for HCC in North America. Hepatology, 80(1), 87–101. https://doi.org/10.1097/hep.0000000000000800

Guha, S., Ibrahim, A., Wu, Q., Geng, P., Chou, Y., Yang, H., Ma, J., Lu, L., Wang, D., Schwartz, L. H., Xie, C., & Zhao, B. (2024). Machine learning-based identification of contrast-enhancement phase of computed tomography scans. PLOS ONE, 19(2), e0294581. https://doi.org/10.1371/journal.pone.0294581

Yanagihara, T. K., Tepper, J. E., Moon, A. M., Barry, A., Molla, M., Seong, J., Torres, F., Apisarnthanarax, S., Buckstein, M., Cardenes, H., Chang, D. T., Feng, M., Guha, C., Hallemeier, C. L., Hawkins, M. A., Hoyer, M., Iwata, H., Jabbour, S. K., Kachnic, L., … Dawson, L. A. (2024). Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus. Practical Radiation Oncology, 14(2), 134–145. https://doi.org/10.1016/j.prro.2023.08.016

Nigam, A., Hawksworth, J. S., & Winslow, E. R. (2024). Minimally Invasive Robotic Techniques for Hepatocellular Carcinoma Resection. Surgical Oncology Clinics of North America, 33(1), 111–132. https://doi.org/10.1016/j.soc.2023.06.009

Ivanics, T., Claasen, M. P. A. W., Samstein, B., Emond, J. C., Fox, A. N., Pomfret, E., Pomposelli, J., Tabrizian, P., Florman, S. S., Mehta, N., Roberts, J. P., Emamaullee, J. A., Genyk, Y., Hernandez-Alejandro, R., Tomiyama, K., Sasaki, K., Hashimoto, K., Nagai, S., … Abouljoud, M. (2023). Living Donor Liver Transplantation for Hepatocellular Carcinoma Within and Outside Traditional Selection Criteria. Annals of Surgery, 279(1), 104–111. https://doi.org/10.1097/sla.0000000000006049

Phipps, M. M., Choi, A. J., & Brown Jr, R. S. (2024). Narrative review of management of cirrhosis during the treatment of hepatocellular carcinoma. Annals of Palliative Medicine, 13(1), 141–149. https://doi.org/10.21037/apm-23-173

Wang, M., Shui, A. M., Ruck, J., King, E., Rahimi, R., Kappus, M., Volk, M. L., Ganger, D. R., Ladner, D. P., Duarte‐Rojo, A., Huang, C., Verna, E. C., & Lai, J. C. (2023). The liver frailty index is a predictor of healthcare utilization after liver transplantation in older adults. Clinical Transplantation, 38(1). Portico. https://doi.org/10.1111/ctr.15219

Ebrahimi, F., Hagström, H., Sun, J., Bergman, D., Shang, Y., Yang, W., Roelstraete, B., & Ludvigsson, J. F. (2023). Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study. Journal of Hepatology, 79(6), 1374–1384. https://doi.org/10.1016/j.jhep.2023.08.018

Itzel, T., Falconer, T., Roig, A., Daza, J., Park, J., Cheong, J. Y., Park, R. W., Wiest, I., Ebert, M. P., Hripcsak, G., & Teufel, A. (2023). Efficacy of Co-Medications in Patients with Alcoholic Liver Disease. Digestive Diseases, 41(5), 780–788. Portico. https://doi.org/10.1159/000529914

Nasr, P., von Seth, E., Mayerhofer, R., Ndegwa, N., Ludvigsson, J. F., & Hagström, H. (2023). Incidence, prevalence and mortality of chronic liver diseases in Sweden between 2005 and 2019. European Journal of Epidemiology, 38(9), 973–984. https://doi.org/10.1007/s10654-023-01028-x

Affo, S., Filliol, A., Gores, G. J., & Schwabe, R. F. (2023). Fibroblasts in liver cancer: functions and therapeutic translation. The Lancet Gastroenterology & Hepatology, 8(8), 748–759. https://doi.org/10.1016/s2468-1253(23)00111-5

Tran, B. V., Moris, D., Markovic, D., Zaribafzadeh, H., Henao, R., Lai, Q., Florman, S. S., Tabrizian, P., Haydel, B., Ruiz, R. M., Klintmalm, G. B., Lee, D. D., Taner, C. B., Hoteit, M., Levine, M. H., Cillo, U., Vitale, A., Verna, E. C., Halazun, K. J., … Agopian, V. G. (2023). Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US Multicenter HCC Transplant Consortium. Liver Transplantation, 29(7), 683–697. https://doi.org/10.1097/lvt.0000000000000145

Saito, Y., Yin, D., Kubota, N., Wang, X., Filliol, A., Remotti, H., Nair, A., Fazlollahi, L., Hoshida, Y., Tabas, I., Wangensteen, K. J., & Schwabe, R. F. (2023). A Therapeutically Targetable TAZ-TEAD2 Pathway Drives the Growth of Hepatocellular Carcinoma via ANLN and KIF23. Gastroenterology, 164(7), 1279–1292. https://doi.org/10.1053/j.gastro.2023.02.043

Sharma, R., Schluger, A., Ahmed, F. S., Nobel, Y. R., Guo, X., Zhao, B., & Verna, E. C. (2023). Visceral adiposity in cirrhosis: Association with disease severity and impact of liver transplantation. Hepatology Communications, 7(6). https://doi.org/10.1097/hc9.0000000000000113

Kelsall, N. C., Sanchez, S. E., Rondon, M. B., Valeri, L., Juvinao-Quintero, D., Kirschbaum, C., Koenen, K. C., & Gelaye, B. (2023). Association between trauma exposure and glucocorticosteroid concentration in hair during pregnancy. Psychoneuroendocrinology, 151, 106072. https://doi.org/10.1016/j.psyneuen.2023.106072

Singal, A. G., Ghaziani, T. T., Mehta, N., Zhou, K., Grinspan, L. T., Benhammou, J. N., Moon, A. M., Yang, J. D., Salgia, R., Pillai, A., Zheng, E., Rich, N. E., Gopal, P., Jalal, P., Verna, E., Yekkaluri, S., Phen, S., Melendez-Torres, J., Alshuwaykh, O., … Parikh, N. D. (2023). Recall patterns and risk of primary liver cancer for subcentimeter ultrasound liver observations: a multicenter study. Hepatology Communications, 7(3). https://doi.org/10.1097/hc9.0000000000000073

Verna, E. C., Phipps, M. M., Halazun, K. J., Markovic, D., Florman, S. S., Haydel, B. M., Ruiz, R., Klintmalm, G., Lee, D. D., Taner, B., Hoteit, M. A., Tevar, A. D., Humar, A., Chapman, W. C., Vachharajani, N., Aucejo, F. N., Melcher, M. L., Nguyen, M. H., … Nydam, T. L. (2022). Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium. Liver Transplantation, 29(1), 34–47. https://doi.org/10.1097/lvt.0000000000000007

Di Benedetto, F., Magistri, P., Di Sandro, S., Sposito, C., Oberkofler, C., Brandon, E., Samstein, B., Guidetti, C., Papageorgiou, A., Frassoni, S., Bagnardi, V., Clavien, P.-A., Citterio, D., Kato, T., Petrowsky, H., Halazun, K. J., Mazzaferro, V., Catellani, B., … Flores, M. (2023). Safety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma. JAMA Surgery, 158(1), 46. https://doi.org/10.1001/jamasurg.2022.5697

Yeoh, B. S., Saha, P., Golonka, R. M., Zou, J., Petrick, J. L., Abokor, A. A., Xiao, X., Bovilla, V. R., Bretin, A. C. A., Rivera-Esteban, J., Parisi, D., Florio, A. A., Weinstein, S. J., Albanes, D., Freeman, G. J., Gohara, A. F., Ciudin, A., Pericàs, J. M., Joe, B., … Vijay-Kumar, M. (2022). Enterohepatic Shunt-Driven Cholemia Predisposes to Liver Cancer. Gastroenterology, 163(6), 1658-1671.e16. https://doi.org/10.1053/j.gastro.2022.08.033

Filliol, A., Saito, Y., Nair, A., Dapito, D. H., Yu, L.-X., Ravichandra, A., Bhattacharjee, S., Affo, S., Fujiwara, N., Su, H., Sun, Q., Savage, T. M., Wilson-Kanamori, J. R., Caviglia, J. M., Chin, L., Chen, D., Wang, X., Caruso, S., Kang, J. K., … Schwabe, R. F. (2022). Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature, 610(7931), 356–365. https://doi.org/10.1038/s41586-022-05289-6

Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022). Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits. Journal of Hepatology, 77(4), 1136–1160. https://doi.org/10.1016/j.jhep.2022.06.012

Kim, S. H., Navot, B., Guniganti, P., Gavlin, A., Hecht, E. M., & Kierans, A. S. (2022). Liver Transplant for Nonhepatocellular Malignancies: A Review for Radiologists. American Journal of Roentgenology, 219(4), 590–603. https://doi.org/10.2214/ajr.22.27783

Lee, C., Liu, K. H., Singer, G., Miller, G. W., Li, S., Jones, D. P., & Morgan, E. T. (2022). High-Throughput Production of Diverse Xenobiotic Metabolites with Cytochrome P450–Transduced Huh7 Hepatoma Cell Lines. Drug Metabolism and Disposition, 50(9), 1182–1189. https://doi.org/10.1124/dmd.122.000900

Tabrizian, P., Holzner, M. L., Mehta, N., Halazun, K., Agopian, V. G., Yao, F., Busuttil, R. W., Roberts, J., Emond, J. C., Samstein, B., Brown, R. S., Najjar, M., Chapman, W. C., Doyle, M. Mb., Florman, S. S., Schwartz, M. E., & Llovet, J. M. (2022). Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma. JAMA Surgery. https://doi.org/10.1001/jamasurg.2022.2800

Shao, Y.-Y., Chen, P.-S., Lin, L.-I., Lee, B.-S., Ling, A., Cheng, A.-L., Hsu, C., & Ou, D.-L. (2022). Low miR-10b-3p associated with sorafenib resistance in hepatocellular carcinoma. British Journal of Cancer, 126(12), 1806–1814. https://doi.org/10.1038/s41416-022-01759-w

Boster, J. M., Superina, R., Mazariegos, G. V., Tiao, G. M., Roach, J. P., Lovell, M. A., Greffe, B. S., Yanni, G., Leung, D. H., Elisofon, S. A., McDiarmid, S. V., Gupta, N. A., Lobritto, S. J., Lemoine, C., Stoll, J. M., Vitola, B. E., Daniel, J. F., Sayed, B. A., Desai, D. M., … Sundaram, S. S. (2022). Predictors of survival following liver transplantation for pediatric hepatoblastoma and hepatocellular carcinoma: Experience from the Society of Pediatric Liver Transplantation (SPLIT). American Journal of Transplantation, 22(5), 1396–1408. https://doi.org/10.1111/ajt.16945

Chow, R., Simone, C. B., Jairam, M. P., Swaminath, A., Boldt, G., & Lock, M. (2022). Comparing treatment modalities for hepatocellular carcinoma: the value of network meta-analyses. Acta Oncologica, 61(4), 495–495. https://doi.org/10.1080/0284186x.2022.2025613